Adicet Bio, Inc. (ACET)
9.59
+0.16
(+1.70%)
USD |
NASDAQ |
Sep 04, 16:00
9.63
+0.04
(+0.42%)
After-Hours: 20:00
Adicet Bio Shareholders Equity (Quarterly) : 120.14M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 120.14M |
| March 31, 2026 | 140.06M |
| December 31, 2025 | 159.21M |
| September 30, 2025 | 109.14M |
| June 30, 2025 | 133.37M |
| March 31, 2025 | 161.45M |
| December 31, 2024 | 186.61M |
| September 30, 2024 | 211.53M |
| June 30, 2024 | 235.11M |
| March 31, 2024 | 258.80M |
| December 31, 2023 | 170.18M |
| September 30, 2023 | 194.68M |
| June 30, 2023 | 239.06M |
| March 31, 2023 | 266.22M |
| December 31, 2022 | 292.34M |
| September 30, 2022 | 317.66M |
| June 30, 2022 | 293.27M |
| March 31, 2022 | 311.08M |
| Date | Value |
|---|---|
| December 31, 2021 | 303.13M |
| September 30, 2021 | 217.22M |
| June 30, 2021 | 228.34M |
| March 31, 2021 | 236.26M |
| December 31, 2020 | 109.83M |
| September 30, 2020 | 116.93M |
| June 30, 2020 | 70.74M |
| March 31, 2020 | 75.62M |
| December 31, 2019 | -60.37M |
| September 30, 2019 | 109.76M |
| June 30, 2019 | 126.94M |
| March 31, 2019 | 140.46M |
| December 31, 2018 | 104.20M |
| September 30, 2018 | 109.34M |
| June 30, 2018 | 117.16M |
| March 31, 2018 | 130.38M |
| December 31, 2017 | 49.69M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 148.17M |
| Total Liabilities (Quarterly) | 28.03M |
| Debt to Equity Ratio | 0.107 |
| Current Ratio | 6.709 |
| Net Debt Paydown Yield | 0.84% |